[Effect of antikaliuretics on the development of cardiac lesions in potassium or magnesium deficiencies in the rat].
D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D002712:Chlorides / Q000494:pharmacology; D004032:Diet; D004232:Diuretics / Q000494:pharmacology*; D005260:Female; D006321:Heart / Q000187:drug effects; D006331:Heart Diseases / Q000209:etiology* / Q000473:pathology; D008274:Magnesium / Q000494:pharmacology; D008275:Magnesium Deficiency / Q000150:complications* / Q000473:pathology; D009336:Necrosis; D011188:Potassium / Q000037:antagonists & inhibitors / Q000652:urine; D011189:Potassium Chloride / Q000494:pharmacology; D011191:Potassium Deficiency / Q000150:complications* / Q000473:pathology; D051381:Rats; D013148:Spironolactone / Q000494:pharmacology; D013312:Stress, Physiological / Q000150:complications; D014223:Triamterene / Q000494:pharmacology
D002712:Chlorides; D004232:Diuretics; D013148:Spironolactone; D011189:Potassium Chloride; D000584:Amiloride; D008274:Magnesium; D011188:Potassium; D014223:Triamterene
Effect d'antikaliurétiques dans le développement des lésions cardiaques chez le rat déficient en potassium ou en magnésium.